Las Vegas—New research suggests that the abuse potential of opioid analgesics should be explored in pain patients rather than in “recreational users,” as specified in the FDA’s “Guidance for Industry: Assessment of Abuse Potential of Drugs.”
The initial results of a study in pain patients receiving a modified form of the questionnaire intended for recreational drug users were presented by Tom Alfieri, PhD, director of Medical Affairs Strategic Research at